Gurley KE - Search Results

1

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer.

Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. Lui GYL, et al. Among authors: gurley ke. EBioMedicine. 2020 Oct;60:102988. doi: 10.1016/j.ebiom.2020.102988. Epub 2020 Sep 11. EBioMedicine. 2020. PMID: 32927276 Free PMC article.

2

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.

Shigeta S, Lui GYL, Shaw R, Moser R, Gurley KE, Durenberger G, Rosati R, Diaz RL, Ince TA, Swisher EM, Grandori C, Kemp CJ. Shigeta S, et al. Among authors: gurley ke. Mol Cancer Ther. 2021 Apr;20(4):691-703. doi: 10.1158/1535-7163.MCT-20-0809. Epub 2021 Jan 28. Mol Cancer Ther. 2021. PMID: 33509905 Free PMC article.

3

Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.

Xu C, Nikolova O, Basom RS, Mitchell RM, Shaw R, Moser RD, Park H, Gurley KE, Kao MC, Green CL, Schaub FX, Diaz RL, Swan HA, Jang IS, Guinney J, Gadi VK, Margolin AA, Grandori C, Kemp CJ, Méndez E. Xu C, et al. Among authors: gurley ke. Clin Cancer Res. 2018 Jun 15;24(12):2828-2843. doi: 10.1158/1078-0432.CCR-17-1339. Epub 2018 Mar 29. Clin Cancer Res. 2018. PMID: 29599409 Free PMC article.

4

Induction of Colon Cancer in Mice with 1,2-Dimethylhydrazine.

Gurley KE, Moser RD, Kemp CJ. Gurley KE, et al. Cold Spring Harb Protoc. 2015 Sep 1;2015(9):pdb.prot077453. doi: 10.1101/pdb.prot077453. Cold Spring Harb Protoc. 2015. PMID: 26330619

5

Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma.

Moser R, Gurley KE, Nikolova O, Qin G, Joshi R, Mendez E, Shmulevich I, Ashley A, Grandori C, Kemp CJ. Moser R, et al. Among authors: gurley ke. Oncogene. 2022 Jun;41(24):3355-3369. doi: 10.1038/s41388-022-02330-w. Epub 2022 May 10. Oncogene. 2022. PMID: 35538224

6

p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient scid mice.

Gurley KE, Kemp CJ. Gurley KE, et al. Carcinogenesis. 1996 Dec;17(12):2537-42. doi: 10.1093/carcin/17.12.2537. Carcinogenesis. 1996. PMID: 9006086

7

Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis.

Gurley KE, Kemp CJ. Gurley KE, et al. Curr Biol. 2001 Feb 6;11(3):191-4. doi: 10.1016/s0960-9822(01)00048-3. Curr Biol. 2001. PMID: 11231155 Free article.

8

Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissues.

Gurley KE, Kemp CJ. Gurley KE, et al. Mol Cancer Res. 2007 Dec;5(12):1312-8. doi: 10.1158/1541-7786.MCR-07-0223. Mol Cancer Res. 2007. PMID: 18171989

9

MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.

Moser R, Toyoshima M, Robinson K, Gurley KE, Howie HL, Davison J, Morgan M, Kemp CJ, Grandori C. Moser R, et al. Among authors: gurley ke. Mol Cancer Res. 2012 Apr;10(4):535-45. doi: 10.1158/1541-7786.MCR-11-0508. Epub 2012 Feb 1. Mol Cancer Res. 2012. PMID: 22301954 Free PMC article.

10

Induction of Lung Tumors in Mice with Urethane.

Gurley KE, Moser RD, Kemp CJ. Gurley KE, et al. Cold Spring Harb Protoc. 2015 Sep 1;2015(9):pdb.prot077446. doi: 10.1101/pdb.prot077446. Cold Spring Harb Protoc. 2015. PMID: 26330618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page